$34.09
0[0.00%]
At close: Apr 25
$34.09
0[0.00%]
PreMarket: 4:20PM EDT
Inhibrx
(NASDAQ:INBX)Inhibrx Stock (NASDAQ:INBX), Earnings Estimates, EPS, and Revenue
Inhibrx reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 10
EPS Estimate
$-1.050
Quarterly Revenue Estimate
$50K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.8M
Analyze the earnings history of Inhibrx using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/10/2024 | PM | INBX | Q1 | -$1.12 | -$1.05 | — | — | $17.00K | $50.00K | — | — | Get Alert |
| 02/28/2024 | AM | INBX | Q4 | -$0.95 | -$1.04 | -$1.73 | -66.35% | $274.00K | $50.00K | $1.63M | 3168.00% | Get Alert |
| 11/09/2023 | PM | INBX | Q3 | -$0.90 | -$1.01 | -$1.10 | -8.91% | $278.00K | — | $119.00K | — | Get Alert |
| 08/07/2023 | PM | INBX | Q2 | -$0.97 | -$1.03 | -$1.08 | -4.85% | $711.00K | — | $30.00K | — | Get Alert |
| 05/08/2023 | PM | INBX | Q1 | -$0.80 | -$0.84 | -$1.12 | -33.33% | $929.00K | $150.00K | $17.00K | -88.67% | Get Alert |
| 03/06/2023 | PM | INBX | Q4 | -$0.55 | -$0.79 | -$0.95 | -20.25% | $2.86M | $790.00K | $274.00K | -65.32% | Get Alert |
| 11/07/2022 | PM | INBX | Q3 | -$0.54 | -$0.94 | -$0.90 | 4.26% | $2.53M | $630.00K | $278.00K | -55.87% | Get Alert |
| 08/08/2022 | PM | INBX | Q2 | -$0.55 | -$0.78 | -$0.97 | -24.36% | $954.00K | $1.07M | $711.00K | -33.55% | Get Alert |
| 05/09/2022 | PM | INBX | Q1 | -$0.51 | — | -$0.80 | — | $889.00K | — | $929.00K | — | Get Alert |
| 02/28/2022 | AM | INBX | Q4 | -$0.47 | — | -$0.55 | — | $2.78M | — | $2.86M | — | Get Alert |
| 11/09/2021 | PM | INBX | Q3 | -$0.77 | -$0.57 | -$0.54 | 5.26% | $5.90M | $1.00M | $2.53M | 153.20% | Get Alert |
| 08/09/2021 | PM | INBX | Q2 | -$0.99 | -$0.56 | -$0.55 | 1.79% | — | $820.00K | $954.00K | 16.34% | Get Alert |
| 05/13/2021 | PM | INBX | Q1 | -$1.11 | -$0.56 | -$0.51 | 8.93% | — | $920.00K | $889.00K | -3.37% | Get Alert |
| 03/12/2021 | AM | INBX | Q4 | — | — | -$0.47 | — | — | — | $2.78M | — | Get Alert |
| 11/13/2020 | PM | INBX | Q3 | -$1.11 | -$0.60 | -$0.77 | -28.33% | $1.22M | $1.00M | $5.90M | 490.10% | Get Alert |
FAQ
When is Inhibrx (NASDAQ:INBX) reporting earnings?
Inhibrx (INBX) is scheduled to report earnings on May 10, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
What were the latest earnings per share (EPS) for Inhibrx (NASDAQ:INBX)?
The Actual EPS was $-1.73, which missed the estimate of $-1.04.
What were Inhibrx’s (NASDAQ:INBX) revenues?
The Actual Revenue was $1.6M, which beat the estimate of $50K.
Browse earnings estimates, EPS, and revenue on all stocks.